Santam (SNT)
Johannesburg Exchange · South Africa · prices in ZAC · close of 22 Oct 2026
Key indicators
| Last close | ZAC 48,488.00 |
|---|---|
| 52-week range | 36,011.00 – 49,007.00 |
| Return, 1 month / 3 months | +19.7% / +22.2% |
| Return, 1 year / 3 years | +21.8% / +78.8% |
| Trend | Uptrend |
| RSI (14) | 77 |
| Volatility (1 year) | 27.0% |
| Worst drawdown (1 year) | -19.8% |
| Average daily value traded | 5,740.07M ZAC |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Santam is a short-term insurance company based in South Africa. It provides cover for individuals and businesses, including motor, property, household, commercial and liability insurance, along with related risk management services. Its customers range from private policyholders to small businesses and larger corporate clients, and it distributes its products through intermediaries and brokers across southern Africa.
Santam trades under the code SNT on the Johannesburg Exchange in South Africa, with its price quoted in South African cents (ZAC). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Santam (SNT) trades on the Johannesburg Exchange in South Africa. It last closed at ZAC 48,488.00 on 22 October 2026.
Its price-based Market X-Ray is 78 out of 100 (a strong price profile), ranking 13 of 238 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 21.8% and over the last three months it rose 22.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Johannesburg Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 90 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 17.7% | ||
| From 52-week high | 0.0% | ||
| Momentum | 76 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 22.2% | ||
| 6-month return | 20.3% | ||
| 12-month return, skipping the last month | 1.8% | ||
| Stability (higher is calmer) | 69 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 27.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -19.8% | ||
| Liquidity | 74 · Strong | Trades actively. | |
| Average daily value traded | 5,740.07M ZAC | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 2 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −0.0% |
|---|---|
| 1 month | +19.7% |
| 3 months | +22.2% |
| 6 months | +20.3% |
| 1 year | +21.8% |
| 3 years | +78.8% |
| 5 years | +107.1% |
Signals
| 50-day / 200-day average | 42,907.54 / 41,190.20 |
|---|---|
| Golden / death cross (60 days) | Golden, 12 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 702.82 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 22 Mar 2023 | ZAC 845.0000 |
| 21 Sep 2022 | ZAC 462.0000 |
| 23 Mar 2022 | ZAC 790.0000 |
| 21 Sep 2021 | ZAC 432.0000 |
| 25 Mar 2020 | ZAC 718.0000 |
| 18 Sep 2019 | ZAC 392.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Johannesburg Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.